Drug class
Centrally acting skeletal muscle relaxant; oxazolidinone derivative
Mechanism of action
The precise mechanism is not fully characterised. Mephenoxalone produces central nervous system depression and reduces muscle hyperactivity and spasm; it is structurally related to older centrally acting muscle relaxants.
General use cases
- Short-term symptomatic treatment of painful muscle spasm associated with musculoskeletal conditions in countries where mephenoxalone is authorised.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
